The Impact of Versatile Macrophage Functions on Acute Kidney Injury and Its Outcomes

Overview

Journal Front Physiol

Date 2019 Aug 27

PMID 31447703

Citations 16

Authors

Jea-Hyun Baek

Affiliations

Soon will be listed here.

Abstract

Acute kidney injury (AKI) is a common and devastating clinical condition with a high morbidity and mortality rate and is associated with a rapid decline of kidney function mostly resulting from the injury of proximal tubules. AKI is typically accompanied by inflammation and immune activation and involves macrophages (Mϕ) from the beginning: The inflamed kidney recruits "classically" activated (M1) Mϕ, which are initially poised to destroy potential pathogens, exacerbating inflammation. Of note, they soon turn into "alternatively" activated (M2) Mϕ and promote immunosuppression and tissue regeneration. Based on their roles in kidney recovery, there is a growing interest to use M2 Mϕ and Mϕ-modulating agents therapeutically against AKI. However, it is pertinent to note that the clinical translation of Mϕ-based therapies needs to be critically reviewed and questioned since Mϕ are functionally plastic with versatile roles in AKI and some Mϕ functions are detrimental to the kidney during AKI. In this review, we discuss the current state of knowledge on the biology of different Mϕ subtypes during AKI and, especially, on their role in AKI and assess the impact of versatile Mϕ functions on AKI based on the findings from translational AKI studies.

Citing Articles

Chronic kidney disease activates the HDAC6-inflammatory axis in the heart and contributes to myocardial remodeling in mice: inhibition of HDAC6 alleviates chronic kidney disease-induced myocardial remodeling.

Kundu S, Gairola S, Verma S, Mugale M, Sahu B Basic Res Cardiol. 2024; 119(5):831-852.

PMID: 38771318 DOI: 10.1007/s00395-024-01056-y.

Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages.

Rendra E, Uhlig S, Moskal I, Thielemann C, Kluter H, Bieback K Cells. 2024; 13(2).

PMID: 38247813 PMC: 10814170. DOI: 10.3390/cells13020121.

Macrophages promote Fibrinogenesis during kidney injury.

Oh H, Kwon O, Kong M, Park K, Baek J Front Med (Lausanne). 2023; 10:1206362.

PMID: 37425313 PMC: 10325639. DOI: 10.3389/fmed.2023.1206362.

Immune Cells Are Differentially Modulated in the Heart and the Kidney during the Development of Cardiorenal Syndrome 3.

Vernier I, Neres-Santos R, Andrade-Oliveira V, Carneiro-Ramos M Cells. 2023; 12(4).

PMID: 36831272 PMC: 9953884. DOI: 10.3390/cells12040605.

The Hippo pathway and its correlation with acute kidney injury.

Zhang C, Li C, Xu K, Zheng Z, Cheng G, Wu H Zool Res. 2022; 43(5):897-910.

PMID: 36052554 PMC: 9486510. DOI: 10.24272/j.issn.2095-8137.2022.110.

References

Mills C, Kincaid K, Alt J, Heilman M, Hill A . M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000; 164(12):6166-73. DOI: 10.4049/jimmunol.164.12.6166. View

Lutz M, SURI R, Niimi M, OGILVIE A, Kukutsch N, Rossner S . Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol. 2000; 30(7):1813-22. DOI: 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8. View

Isbel N, Hill P, Foti R, Mu W, HURST L, Stambe C . Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int. 2001; 60(2):614-25. DOI: 10.1046/j.1523-1755.2001.060002614.x. View

Nikolic-Paterson D, Atkins R . The role of macrophages in glomerulonephritis. Nephrol Dial Transplant. 2001; 16 Suppl 5:3-7. DOI: 10.1093/ndt/16.suppl_5.3. View

Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt S . Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 2001; 60(6):2118-28. DOI: 10.1046/j.1523-1755.2001.00043.x. View

Wilson H, Stewart K, Brown P, Anegon I, Chettibi S, Rees A . Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther. 2002; 6(6):710-7. DOI: 10.1006/mthe.2002.0802. View

Lenda D, Kikawada E, Stanley E, Kelley V . Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol. 2003; 170(6):3254-62. DOI: 10.4049/jimmunol.170.6.3254. View

Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H . CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol. 2003; 14(10):2503-15. DOI: 10.1097/01.asn.0000089563.63641.a8. View

Day Y, Huang L, Ye H, Linden J, Okusa M . Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol. 2004; 288(4):F722-31. DOI: 10.1152/ajprenal.00378.2004. View

10.

Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus M, Cantino D . Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005; 166(2):545-55. PMC: 1602314. DOI: 10.1016/S0002-9440(10)62276-6. View

11.

Wang W, Huang X, Li A, Liu F, Li J, Truong L . Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol. 2005; 16(5):1371-83. DOI: 10.1681/ASN.2004121070. View

12.

Jo S, Sung S, Cho W, Go K, Kim H . Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant. 2006; 21(5):1231-9. DOI: 10.1093/ndt/gfk047. View

13.

Wang Y, Wang Y, Zheng G, Lee V, Ouyang L, Chang D . Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 2007; 72(3):290-9. DOI: 10.1038/sj.ki.5002275. View

14.

Lu L, Oh D, Dursun B, He Z, Hoke T, Faubel S . Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J Pharmacol Exp Ther. 2007; 324(1):111-7. DOI: 10.1124/jpet.107.130161. View

15.

Vinuesa E, Hotter G, Jung M, Herrero-Fresneda I, Torras J, Sola A . Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. J Pathol. 2007; 214(1):104-13. DOI: 10.1002/path.2259. View

16.

Ko G, Boo C, Jo S, Cho W, Kim H . Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant. 2007; 23(3):842-52. DOI: 10.1093/ndt/gfm694. View

17.

Oh D, Dursun B, He Z, Lu L, Hoke T, Ljubanovic D . Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol. 2007; 294(1):F264-71. DOI: 10.1152/ajprenal.00204.2007. View

18.

Reeves W, Kwon O, Ramesh G . Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury. Am J Physiol Renal Physiol. 2008; 294(4):F731-8. DOI: 10.1152/ajprenal.00507.2007. View

19.

Jang H, Kim J, Park Y, Park K . Infiltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys. Transplantation. 2008; 85(3):447-55. DOI: 10.1097/TP.0b013e318160f0d1. View

20.

Li L, Huang L, Sung S, Vergis A, Rosin D, Rose Jr C . The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int. 2008; 74(12):1526-37. PMC: 2652647. DOI: 10.1038/ki.2008.500. View